About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Pancreatic Cancer Clinical Trials | 4,765 Studies Recruiting

Clinical TrialsPancreatic Cancer

Pancreatic Cancer Clinical Trials

Browse 4,765 clinical trials for pancreatic cancer. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 701-720 of 4,765 trials

UnknownNKG2D/CLDN18.2 CAR-T(KD-496) in the Treatment of Advanced NKG2DL+/CLDN18.2+ Solid TumorsThis is a Phase 1, single-arm, single-center, open-label study to evaluate the safety and effectiveness of NKG2D/CLDN18.2-based CAR-T cells infusion in the treatment of advanced…NCT05583201·Beijing Enrolling by invitationThe Differences of Complications Between LPD(Laparoscopic Pancreaticoduodenectomy) and OPD(Open Pancreaticoduodenectomy)Main objective: This project intends to design a simulated RCT project and clinically relevant RCT study to target, selecting the study titled "Short-Term outcomes Following…NCT06685939·Shanghai CompletedComparative Study Between Immediate Surgery Versus Neoadjuvant Chemotherapy for Management of Resectable Pancreatic CancerThis trial aimed to determine whether neoadjuvant chemoradiotherapy improves overall survival compared with upfront surgery, both followed by adjuvant chemotherapy in patients…NCT06978322·Minya, Minya Governorate UnknownThe Application of DNA Nanomachines for Detecting microRNA in Blood for the Diagnosis of Pancreatic Cancer. Diagnosis of Pancreatic CancerPrevious research has shown that microRNAs in the blood can serve as biomarkers for early pancreatic cancer, with potential applications including detection, differential…NCT06497777·Taipei

Related Searches

pancreas cancertrials

Data from ClinicalTrials.govTerms

CompletedSafety and Pharmacokinetics of SM04755 in Subjects With Advanced Colorectal, Gastric, Hepatic, or Pancreatic CancerThis is an open-label, multi-center, dose escalation study in adult subjects with advanced colorectal, gastric, hepatic or pancreatic cancer.NCT02191761·Scottsdale, Arizona and 2 others

Active not recruitingEnhanced Outpatient Symptom Management to Reduce Acute Care Visits Due to Chemotherapy-Related Adverse EventsThis clinical trial studies if enhanced outpatient symptom management with telemedicine and remote monitoring can help reduce acute care visit due to chemotherapy-related adverse…NCT05038254·Houston, Texas

UnknownStudy of NAC of GA Therapy for Patients With BRPCGemcitabine plus nub-paclitaxel (GA) regimen was recently presented at an international oncology meeting and represents a new standard regimen in the treatment of metastatic…NCT02926183·Hirosaki, Aomori and 17 others

Not yet recruitingEUS-guided CDS vs ERCP as First Line in Malignant Distal Obstruction in Borderline Disease (CARPEDIEM-2 Trial)The aim of this clinical trial is to evaluate temporal delay (days) between biliary drainage (EUS-CDS vs ERCP as first line therapy) and chemotherapy start in patients with…NCT06375954·L'Hospitalet de Llobregat, Barcelona

RecruitingA Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid TumorsThis is a first-in-human (FIH), multicenter, open-label Phase I study to investigate the safety, tolerability, preliminary antitumor activity, as well as pharmacokinetics (PK) and…NCT05932862·Fountain Valley, California and 15 others

CompletedA Study of Gemcitabine, Nab-paclitaxel, Capecitabine, Cisplatin, and Irinotecan in Metastatic Pancreatic CancerThe purpose of this study is to evaluate the clinical activity of gemcitabine, nab-paclitaxel, capecitabine, cisplatin, and irinotecan (GAX-CI) in patients with metastatic…NCT03535727·Baltimore, Maryland

SuspendedA Study of Gemcitabine ± Erlotinib and DN-101 Versus Gemcitabine ± Erlotinib and Placebo in Patients With Advanced Pancreatic CancerThe purpose of this study is to determine the safety and efficacy of an investigational study drug DN-101 (calcitriol) when given in combination with gemcitabine ± erlotinib in…NCT00536770·Nashville, Tennessee

TerminatedClinical Utility of Selected Circulating Tumor DNA Assays in Patients With Advanced MalignancyCirculating tumor DNA assays are becoming relevant for routine diagnostics, but many related aspects are yet unresolved.NCT06290856·Oslo

TerminatedMonitoring Heart Rate Variability for the Early Detection of Pancreatic CancerThis study examines heart rate monitoring variability for the early detection of pancreatic cancer. Pancreatic cancer is a very difficult disease to detect early.NCT04400903·Omaha, Nebraska and 2 others

UnknownPERiX: Comparison of Efficacy Between Placement of Epidural Catheters X-ray Guided and LOS TechniqueThe use of epidural catheters for postoperative analgesia in pancreatic surgery is recommended by the guidelines of the ERAS society.NCT03685370·Verona, Veneto

UnknownMicrometastasis in Gastrointestinal CancerPrognostic and predictive value of assessing the patients micrometastasis status in blood and bone marrow when diagnosed GI cancer.NCT01919151·Oslo, Oslo

RecruitingNALIRIFOX+Adebrelimab+PULSAR for Advanced Pancreatic CancerThis study aims to evaluate the safety and preliminary efficacy of NALIRIFOX combined with adebrelimab and PULSAR as first-line treatment for locally advanced unresectable or…NCT07595172·Chengdu, Sichuan

UnknownAnlotinib Plus Anti-PD-1 Antibody AK105 for Advanced Pancreatic CancerThis study was designed to explore the clinical efficacy of Anlotinib combined with Anti-PD-1 antibody AK105 in the treatment of third- and above -line advanced pancreatic cancer…NCT04803851·Beijing, Beijing Municipality

RecruitingPhase I Study of [177Lu]Lu-DFC413 in Patients With Solid TumorsThe purpose of this study is to evaluate the safety, tolerability, dosimetry and preliminary efficacy of \[177Lu\]Lu-DFC413 and safety and imaging properties of \[68Ga\]Ga-NNS309…NCT07261631·Montreal, Quebec and 7 others

RecruitingiExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D MutationThis phase I trial studies the best dose and side effects of mesenchymal stromal cells-derived exosomes with KrasG12D siRNA (iExosomes) in treating participants with pancreatic…NCT03608631·Houston, Texas

CompletedA Study of GSK2256098 and Trametinib in Advanced Pancreatic CancerThis is a phase 2 study (the second phase in testing a new drug or combination to see how effect the drug or combination is) of investigational drugs GSK2256098 and Trametinib.NCT02428270·Hamilton, Ontario and 3 others

PreviousPage 36 of 239Next